Filana Therapeutics, Inc. FLNA
Set alert
0.62 USD -0.04 -5.47%
At close
0.65 +0.03 +4.50%
Pre-market · Nov 2, 4:05 AM ET
0.62 Day range 0.6585
0.60 52-week range 3.45
- YTD
- -68.59%
- 1 year
- -80.92%
- Open
- 0.6585
- Prev close
- 0.658
- Mkt cap
- 30.05M
- Vol
- 215.57K
- Avg vol
- 2.02M
- EPS
- -0.87
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.62
- High
- 0.6585
1M chart
Signals (7)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 29, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 5, 2026 | 3 weeks ago |
Financials — quick view
FLNA Revenue — quarterly 0
FLNA Net income — quarterly -8.60M
FLNA EPS — quarterly -0.18
News
- Filana Therapeutics Announces A Study Published By Yale Researchers Of New Preclinical Research On Simufilam Examined Simufilam's Impacts In Human Cell Line To Eliminate Tuberous Sclerosis Complex 2 Gene To Model Cellular Changes
- Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
Your note
Sign in to keep a note on FLNA — it syncs with the Stock Master app.